(Updated - June 23, 2022 7:41 AM EDT)

Stifel analyst Paul Matteis downgraded Athira Pharma (NASDAQ: ATHA) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE